Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

Xue E.; Tresoldi C.; Sala E.; Crippa A.; Mazzi B.; Greco R.; Messina C.; Carrabba M. G.; Stanghellini M. T. Lupo; Marktel S.; Corti C.; Peccatori J.; Bernardi M.; Ciceri F.; Vago L.

首页> 外文期刊>Bone marrow transplantation >Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

【24h】

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

机译：纵向qPCR监测同种异体造血干细胞移植后核磷蛋白1突变以预测AML复发

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2016年第3期|共4页
作者
Xue E.; Tresoldi C.; Sala E.; Crippa A.; Mazzi B.; Greco R.; Messina C.; Carrabba M. G.; Stanghellini M. T. Lupo; Marktel S.; Corti C.; Peccatori J.; Bernardi M.; Ciceri F.; Vago L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse [J] . Xue E., Tresoldi C., Sala E., Bone marrow transplantation . 2016,第3期

机译：纵向qPCR监测同种异体造血干细胞移植后核磷蛋白1突变以预测AML复发
2. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. [J] . Kroger N, Bacher U, Bader P, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第10期

机译：NCI第一次国际研讨会，关于异基因造血干细胞移植后复发的生物学，预防和治疗：来自疾病特异性方法和策略委员会的报告，用于监测异基因干细胞移植后的复发。第二部分：慢性白血病，骨髓增生性肿瘤和淋巴样恶性肿瘤。
3. Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia [J] . Mingzhu Xua, Hong Liu, Yuejun Liu, Leukemia and lymphoma . 2019,第11a12期

机译：基因突变和预挥发膜最小的残留疾病预测成年血管生效性干细胞移植治疗T细胞急性淋巴细胞白血病后成人患者复发风险
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. NCI First International Workshop on the Biology Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation [O] . David L. Porter, Edwin P. Alyea, Joseph H. Antin, -1

机译：生物学造血干细胞移植后复发后复发后的生物学预防和治疗第一国际讲习班：异种造血干细胞移植后复发治疗委员会的报告
7. Minimal residual disease monitoring by RQPCR of Ig/TCR rearrangements: an effective method to predict relapse in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation [O] . Victoria A. Lavrinenko, Alexandr N. Meleshko, Dmitry V. Lutskovich, 2018

机译：IG / TCR重排的RQPCR的最小残留疾病监测：在同种异体造血干细胞移植后预测急性淋巴细胞白血病儿童的预测方法

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

著录项

相似文献

相关主题

期刊订阅